Tafazzin TAZ promotes the tumorigenicity of cervical cancer cells and inhibits apoptosisReport as inadecuate




Tafazzin TAZ promotes the tumorigenicity of cervical cancer cells and inhibits apoptosis - Download this document for free, or read online. Document in PDF available to download.

Tafazzin TAZ is often aberrantly expressed in some cancers, including rectal cancer and thyroid neoplasms. However, the function of TAZ in cervical cancer cells remains unknown. This study aims to explore the expression and function of TAZ in cervical cancer cells. Here, we determined the expression of TAZ protein in normal cervical tissue NC, n = 27, high-grade squamous intraepithelial lesions HSIL, n = 26 and squamous cervical carcinoma SCC, n = 41 by immunohistochemistry, the expression of TAZ protein gradually increased from NC to HSIL to SCC. TAZ was overexpressed or down-regulated in cervical cancer cells by stably transfecting a TAZ-expressing plasmid or a shRNA plasmid targeting TAZ. In vitro, the cell growth curves and MTT assays showed that TAZ may promote the growth and viability of cervical cancer cells. In vivo, xenografts experiment showed that TAZ may increase tumor-forming ability. The percentage of apoptosis cells analyzed by FACS and TUNEL assays consistently showed that TAZ inhibits apoptosis in cervical cancer cells. Furthermore, the Cleaved Caspase 9 and Cleaved Caspase 3 were down-regulated by TAZ in cervical cancer cells. Taken together, this study demonstrated that TAZ is overexpressed in cervical cancer and may promote tumorigenicity of cervical cancer cells and inhibit apoptosis.



Author: Mei Chen, Yuan Zhang, Peng-Sheng Zheng

Source: http://plos.srce.hr/



DOWNLOAD PDF




Related documents